Optiver Holding
REPL icon

Optiver Holding’s Replimune Group REPL Stock Holding History

Optiver Holding’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.23K Buy
553
+240
+77% +$1.83K ﹤0.01% 1493
2025
Q4 		$3.04K Buy
313
+143
+84% +$1.22K ﹤0.01% 1745
2025
Q3 		$712 Buy
+170
New +$1.09K ﹤0.01% 2533

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Optiver Holding's REPL Position: Q1 2026 in Review

Optiver Holding increased its Replimune Group (REPL) stake by 77% in Q1 2026, buying an estimated $1.83K and bringing the position to 553 shares worth $4.23K. The position accounts for ﹤0.01% of the portfolio, ranked #1493.

Optiver Holding first reported a position in REPL in Q3 2025 and has held it in 3 quarters since. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • Optiver Holding held 553 shares of Replimune Group worth $4.23K as of Q1 2026.
  • Optiver Holding bought 240 Replimune Group shares in Q1 2026, an estimated $1.83K.
  • Replimune Group made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #1493 holding.
  • Optiver Holding first reported a position in Replimune Group in Q3 2025 and has held it in 3 quarters since.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.